Giulia Pellizzari
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Immune cells in cancer 3
- T-cell and B-cell Immunology 1
- Mast cells and histamine 1
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Sophia N. Karagiannis (9 shared papers)James F. Spicer (8 shared papers)Heather J. Bax (7 shared papers)Debra Hannah Josephs (7 shared papers)Kristina M. Ilieva (6 shared papers)Anthony Cheung (2 shared papers)Andrew N.J. Tutt (2 shared papers)James W. Opzoomer (1 shared paper)
- Journals
- Nature Communications (4 papers)Allergy (3 papers)mAbs (2 papers)Oncotarget (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United KingdomAustriaItaly
In The Last Decade
Giulia Pellizzari
20 papers receiving 1.2k citations
Giulia Pellizzari's Hit Papers
Peers
Comparison fields: 5 of 58
- Drug Discovery 1
- Biomaterials 120
- Oncology 172
- Immunology 117
- Radiology, Nuclear Medicine and Imaging 127
Countries citing papers authored by Giulia Pellizzari
This map shows the geographic impact of Giulia Pellizzari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Pellizzari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Pellizzari more than expected).
Fields of papers citing papers by Giulia Pellizzari
This network shows the impact of papers produced by Giulia Pellizzari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Pellizzari. The network helps show where Giulia Pellizzari may publish in the future.
Co-authors
The 25 scholars most cited alongside Giulia Pellizzari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Targeting folate receptor alpha for cancer treatment Hit paper breakdown → | 2016 | 383 |
| 2 | 2019 | 202 | |
| 3 | 2017 | 81 | |
| 4 | 2018 | 80 | |
| 5 | 2017 | 68 | |
| 6 | 2019 | 61 | |
| 7 | 2017 | 59 | |
| 8 | 2020 | 41 | |
| 9 | 2023 | 31 | |
| 10 | 2023 | 29 | |
| 11 | 2023 | 28 | |
| 12 | 2021 | 25 | |
| 13 | 2018 | 23 | |
| 14 | 2020 | 22 | |
| 15 | 2020 | 21 | |
| 16 | 2019 | 18 | |
| 17 | 2016 | 16 | |
| 18 | 2015 | 13 | |
| 19 | 2025 | 12 | |
| 20 | 2020 | 7 |
About Giulia Pellizzari
Giulia Pellizzari is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging, Reproductive Medicine, Rheumatology and Oncology, having authored 20 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immune cells in cancer (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Folate and B Vitamins Research (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Glutathione Transferases and Polymorphisms (1 paper), T-cell and B-cell Immunology (1 paper) and Mast cells and histamine (1 paper). The work is most often cited by research in Drug Discovery (1 citation), Biomaterials (120 citations), Oncology (172 citations), Immunology (117 citations) and Radiology, Nuclear Medicine and Imaging (127 citations). Giulia Pellizzari has collaborated with scholars based in United Kingdom, Austria and Italy. Frequent co-authors include Sophia N. Karagiannis, James F. Spicer, Heather J. Bax, Debra Hannah Josephs, Kristina M. Ilieva, Anthony Cheung, Andrew N.J. Tutt, James W. Opzoomer, Mariangela Figini and Anita E. Grigoriadis. Their work appears in journals such as Nature Communications, Allergy, mAbs, Oncotarget and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.